FAQs about our Team
From 2008.igem.org
Line 21: | Line 21: | ||
<o:Revision>2</o:Revision> | <o:Revision>2</o:Revision> | ||
<o:TotalTime>0</o:TotalTime> | <o:TotalTime>0</o:TotalTime> | ||
- | <o:Created>2008-10-23T00: | + | <o:Created>2008-10-23T00:24:00Z</o:Created> |
- | <o:LastSaved>2008-10-23T00: | + | <o:LastSaved>2008-10-23T00:24:00Z</o:LastSaved> |
<o:Pages>1</o:Pages> | <o:Pages>1</o:Pages> | ||
<o:Words>315</o:Words> | <o:Words>315</o:Words> | ||
- | <o:Characters> | + | <o:Characters>1797</o:Characters> |
<o:Company>UCSF</o:Company> | <o:Company>UCSF</o:Company> | ||
- | <o:Lines> | + | <o:Lines>14</o:Lines> |
<o:Paragraphs>3</o:Paragraphs> | <o:Paragraphs>3</o:Paragraphs> | ||
- | <o:CharactersWithSpaces> | + | <o:CharactersWithSpaces>2206</o:CharactersWithSpaces> |
<o:Version>11.1280</o:Version> | <o:Version>11.1280</o:Version> | ||
</o:DocumentProperties> | </o:DocumentProperties> | ||
Line 77: | Line 77: | ||
text-indent:-.25in; | text-indent:-.25in; | ||
mso-pagination:widow-orphan; | mso-pagination:widow-orphan; | ||
- | mso-list:l0 level1 | + | mso-list:l0 level1 lfo3; |
tab-stops:list .5in; | tab-stops:list .5in; | ||
font-size:12.0pt; | font-size:12.0pt; | ||
Line 173: | Line 173: | ||
<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span | <p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span | ||
- | style='font-family:Arial'><b>Q. | + | style='font-size:11.0pt;font-family:Arial'><b>Q. How is control of gene |
- | is control of gene expression by chromatin different from control by transcription | + | expression by chromatin different from control by transcription factors (and |
- | factors (and what are its advantages)?<o:p></o:p></b></span></p> | + | what are its advantages)?<o:p></o:p></b></span></p> |
- | <p class=MsoNormal | + | <p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span |
- | style=' | + | style='font-size:11.0pt;font-family:Arial'><b><![if !supportEmptyParas]> <![endif]><o:p></o:p></b></span></p> |
- | + | ||
- | <p class= | + | <p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b>A. |
- | + | Chromatin is a completely different level of gene expression control.<o:p></o:p></b></span></p> | |
- | + | ||
- | </ | + | |
- | + | ||
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]> | + | </span></span><![endif]><span style='font-size:11.0pt'>Dominant over |
- | + | transcription factors (resistant to noise).<o:p></o:p></span></p> | |
- | + | ||
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]> | + | </span></span><![endif]><span style='font-size:11.0pt'>Regional – |
- | + | silences domains, not individual genes (reduces the engineering required for | |
+ | regulation of complex multi-gene systems).<o:p></o:p></span></p> | ||
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]> | + | </span></span><![endif]><span style='font-size:11.0pt'>Memory–Alteration |
- | ( | + | in gene expression lasts for multiple generations (epigenetic control).<o:p></o:p></span></p> |
- | <p class= | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
+ | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; | ||
+ | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> | ||
+ | </span></span><![endif]><span style='font-size:11.0pt'>Intrinsically bistable, | ||
+ | i.e. all-or-none expression (increases parameter space over which circuits are | ||
+ | predicted to be stable).<o:p></o:p></span></p> | ||
- | <p class=MsoNormal><span style='font-family:Arial'><![if !supportEmptyParas]> <![endif]><o:p></o:p></span></p> | + | <p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><![if !supportEmptyParas]> <![endif]><o:p></o:p></span></p> |
+ | |||
+ | <p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><![if !supportEmptyParas]> <![endif]><o:p></o:p></span></p> | ||
<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span | <p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span | ||
- | style='font-family:Arial'><b>Q. | + | style='font-size:11.0pt;font-family:Arial'><b>Q. What applications could this |
- | applications could this type of synthetic chromatin control system be used for?<o:p></o:p></b></span></p> | + | type of synthetic chromatin control system be used for?<o:p></o:p></b></span></p> |
- | <p class=MsoNormal><span style='font-family:Arial'><b> | + | <p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b><![if !supportEmptyParas]> <![endif]><o:p></o:p></b></span></p> |
- | + | ||
- | + | ||
- | <p class= | + | <p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b>A. To |
- | + | stably and permanently switch cells between different states characterized by | |
- | + | significant differences in gene expression (i.e. cellular differentiation).<o:p></o:p></b></span></p> | |
- | </ | + | |
- | + | ||
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list: | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l2 level2 lfo7; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]>In bio-production– | + | </span></span><![endif]><span style='font-size:11.0pt'>In |
- | + | bio-production–for coordinated switching between a growth phase and a | |
- | + | production phase.<o:p></o:p></span></p> | |
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list: | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l3 level1 lfo9; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]> | + | </span></span><![endif]><span style='font-size:11.0pt'>In |
- | + | bio-production–to differentiate a clonal population of cells into a | |
- | + | distribution of subtypes that function cooperatively (“factory” with different | |
+ | specialized “workers”).<o:p></o:p></span></p> | ||
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]>To | + | </span></span><![endif]><span style='font-size:11.0pt'>To reprogram cell fate |
- | + | in a highly specific manner (e.g. stem cell engineering, correction of | |
+ | epigenetic abnormalities in cancer cells).<o:p></o:p></span></p> | ||
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]>To | + | </span></span><![endif]><span style='font-size:11.0pt'>To create cells with |
- | + | highly digital computational capabilities.<o:p></o:p></span></p> | |
- | <p class= | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
+ | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; | ||
+ | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> | ||
+ | </span></span><![endif]><span style='font-size:11.0pt'>To study chromatin | ||
+ | spreading mechanism in a quantitative and controlled way.<o:p></o:p></span></p> | ||
- | <p class=MsoNormal style='margin-left:.25in'><span style='font-family:Arial'><![if !supportEmptyParas]> <![endif]><o:p></o:p></span></p> | + | <p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt; |
+ | font-family:Arial'><![if !supportEmptyParas]> <![endif]><o:p></o:p></span></p> | ||
- | <p class=MsoNormal><span style='font-family:Arial'>< | + | <p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt; |
- | style=' | + | font-family:Arial'><![if !supportEmptyParas]> <![endif]><o:p></o:p></span></p> |
+ | |||
+ | <p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b>Q. Could | ||
this type of yeast synthetic chromatin control system be utilized in other cell | this type of yeast synthetic chromatin control system be utilized in other cell | ||
types, including mammalian cells?<o:p></o:p></b></span></p> | types, including mammalian cells?<o:p></o:p></b></span></p> | ||
- | <p class=MsoNormal><span style='font-family:Arial'><b> | + | <p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b><![if !supportEmptyParas]> <![endif]><o:p></o:p></b></span></p> |
- | style=' | + | |
+ | <p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b>A. Yes, | ||
the approach should be transferable.<o:p></o:p></b></span></p> | the approach should be transferable.<o:p></o:p></b></span></p> | ||
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]>Core elements of this system are: initiator, covalent | + | </span></span><![endif]><span style='font-size:11.0pt'>Core elements of this |
- | mark, spreading (polymerization).</p> | + | system are: initiator, covalent mark, spreading (polymerization).<o:p></o:p></span></p> |
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]>In <i>S. cerevisiae</i><span style='font- | + | </span></span><![endif]><span style='font-size:11.0pt'>In <i>S. cerevisiae</i></span><span |
- | covalent mark is deacetylation–we use an initiator (LexA-Sir2) that when | + | style='font-size:11.0pt'>, covalent mark is deacetylation–we use an |
- | localized deacetylates adjacent histones.<span style="mso-spacerun: yes"> | + | initiator (LexA-Sir2) that when localized deacetylates adjacent histones.<span |
- | </span>This leads to further recruitment of Sir2, which propagates the mark | + | style="mso-spacerun: yes"> </span>This leads to further recruitment of |
- | outward. Deacetylated chromatin adopts a “closed” conformation. </span></p> | + | Sir2, which propagates the mark outward. Deacetylated chromatin adopts a |
+ | “closed” conformation. <o:p></o:p></span></p> | ||
- | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 | + | <p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5; |
- | tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span | + | tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt; |
- | style='font:7.0pt "Times New Roman"'> | + | font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'> |
- | </span></span><![endif]>For higher eukaryotes, from <i>S. pombe</i><span | + | </span></span><![endif]><span style='font-size:11.0pt'>For higher eukaryotes, |
- | style='font- | + | from <i>S. pombe</i></span><span style='font-size:11.0pt'> to human, the |
- | initiator is a histone methyltransferase. But in principle, a similar system | + | covalent mark is methylation, initiator is a histone methyltransferase. But in |
- | should work.<span style="mso-spacerun: yes"> </span>Same logical design, | + | principle, a similar system should work.<span style="mso-spacerun: yes"> |
- | with different catalytic functions propagating spread.</span></p> | + | </span>Same logical design, with different catalytic functions propagating |
+ | spread.<o:p></o:p></span></p> | ||
- | <p class=MsoNormal><span style='font-family:Arial'><span style="mso-spacerun: | + | <p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><span |
- | yes"> </span><o:p></o:p></span></p> | + | style="mso-spacerun: yes"> </span><o:p></o:p></span></p> |
</div> | </div> | ||
Line 295: | Line 306: | ||
</html> | </html> | ||
- | |||
- | |||
- | |||
Revision as of 00:24, 23 October 2008
Q. How is control of gene
expression by chromatin different from control by transcription factors (and
what are its advantages)?
A.
Chromatin is a completely different level of gene expression control.
·
Dominant over
transcription factors (resistant to noise).
·
Regional –
silences domains, not individual genes (reduces the engineering required for
regulation of complex multi-gene systems).
·
Memory–Alteration
in gene expression lasts for multiple generations (epigenetic control).
·
Intrinsically bistable,
i.e. all-or-none expression (increases parameter space over which circuits are
predicted to be stable).
Q. What applications could this
type of synthetic chromatin control system be used for?
A. To
stably and permanently switch cells between different states characterized by
significant differences in gene expression (i.e. cellular differentiation).
·
In
bio-production–for coordinated switching between a growth phase and a
production phase.
·
In
bio-production–to differentiate a clonal population of cells into a
distribution of subtypes that function cooperatively (“factory” with different
specialized “workers”).
·
To reprogram cell fate
in a highly specific manner (e.g. stem cell engineering, correction of
epigenetic abnormalities in cancer cells).
·
To create cells with
highly digital computational capabilities.
·
To study chromatin
spreading mechanism in a quantitative and controlled way.
Q. Could
this type of yeast synthetic chromatin control system be utilized in other cell
types, including mammalian cells?
A. Yes,
the approach should be transferable.
·
Core elements of this
system are: initiator, covalent mark, spreading (polymerization).
·
In S. cerevisiae, covalent mark is deacetylation–we use an
initiator (LexA-Sir2) that when localized deacetylates adjacent histones. This leads to further recruitment of
Sir2, which propagates the mark outward. Deacetylated chromatin adopts a
“closed” conformation.
·
For higher eukaryotes,
from S. pombe to human, the
covalent mark is methylation, initiator is a histone methyltransferase. But in
principle, a similar system should work.
Same logical design, with different catalytic functions propagating
spread.
Home | The Team | The Project | Parts Submitted to the Registry | Modeling | Human Practices | Notebooks |
---|